Medicine Man Technologies Stock Gross Profit
Medicine Man Technologies fundamentals help investors to digest information that contributes to Medicine Man's financial success or failures. It also enables traders to predict the movement of Medicine OTC Stock. The fundamental analysis module provides a way to measure Medicine Man's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medicine Man otc stock.
Medicine |
Medicine Man Technologies OTC Stock Gross Profit Analysis
Medicine Man's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Medicine Man Gross Profit | 3 M |
Most of Medicine Man's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medicine Man Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, Medicine Man Technologies reported 3 M of gross profit. This is 99.93% lower than that of the Industrials sector and significantly higher than that of the Consulting Services industry. The gross profit for all United States stocks is 99.99% higher than that of the company.
Medicine Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medicine Man's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Medicine Man could also be used in its relative valuation, which is a method of valuing Medicine Man by comparing valuation metrics of similar companies.Medicine Man is currently under evaluation in gross profit category among related companies.
Medicine Fundamentals
| Return On Equity | -0.88 | |||
| Return On Asset | -0.0068 | |||
| Profit Margin | (1.41) % | |||
| Operating Margin | (128.22) % | |||
| Current Valuation | 83.6 M | |||
| Shares Outstanding | 39.95 M | |||
| Shares Owned By Insiders | 40.91 % | |||
| Shares Owned By Institutions | 1.84 % | |||
| Price To Earning | 88.00 X | |||
| Price To Book | 3.20 X | |||
| Price To Sales | 9.72 X | |||
| Revenue | 8.9 M | |||
| Gross Profit | 3 M | |||
| EBITDA | (8.88 M) | |||
| Net Income | (17.77 M) | |||
| Cash And Equivalents | 15.2 M | |||
| Cash Per Share | 0.38 X | |||
| Total Debt | 121.83 K | |||
| Debt To Equity | 0.40 % | |||
| Current Ratio | 2.39 X | |||
| Book Value Per Share | 0.85 X | |||
| Cash Flow From Operations | (7.48 M) | |||
| Earnings Per Share | (0.64) X | |||
| Number Of Employees | 61 | |||
| Beta | 1.65 | |||
| Market Capitalization | 75.91 M | |||
| Total Asset | 454 K | |||
| Retained Earnings | (23.42 M) | |||
| Working Capital | 246 K | |||
| Current Asset | 414 K | |||
| Current Liabilities | 168 K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Medicine Man in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Medicine Man's short interest history, or implied volatility extrapolated from Medicine Man options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Medicine Man Technologies information on this page should be used as a complementary analysis to other Medicine Man's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in Medicine OTC Stock
If you are still planning to invest in Medicine Man Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medicine Man's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |